Showing results (11-20 of 81) with videos related to

Sort By:
Pageof 9
Cancer Chemotherapy and Pharmacology|September 21, 2005
Satraplatin activation by haemoglobin, cytochrome C and liver microsomes in vitroJocelyn L Carr, Malcolm D Tingle, Mark J McKeage
Cancer Chemotherapy and Pharmacology|July 12, 2002
Rapid biotransformation of satraplatin by human red blood cells in vitroJocelyn L Carr, Malcolm D Tingle, Mark J McKeage
The Journal of Pharmacy and Pharmacology|March 1, 1991
Inhibition of dapsone-induced methaemoglobinaemia by cimetidine in the rat during chronic dapsone administrationM D Coleman, M D Tingle, B K Park
British Journal of Clinical Pharmacology|December 1, 1995
N-Hydroxylation of dapsone by multiple enzymes of cytochrome P450: implications for inhibition of haemotoxicityH J Gill, M D Tingle, B K Park
British Journal of Clinical Pharmacology|July 1, 1991
The effect of preincubation with cimetidine on the N-hydroxylation of dapsone by human liver microsomesM D Tingle, M D Coleman, B K Park
British Journal of Clinical Pharmacology|December 1, 1990
An investigation of the role of metabolism in dapsone-induced methaemoglobinaemia using a two compartment in vitro test systemM D Tingle, M D Coleman, B K Park
European Journal of Nutrition|April 24, 2001
Contrasting effects of acute and chronic dietary exposure to 2-amino-3-methyl-imidazo[4,5-f]quinoline (IQ) on xenobiotic metabolising enzymes in the male Fischer 344 rat: implications for chemoprevention studiesR A McPherson, M D Tingle, L R Ferguson
Cancer Chemotherapy and Pharmacology|February 28, 2002
Gender differences in the metabolism and pharmacokinetics of the experimental anticancer agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA)Shufeng Zhou, Philip Kestell, Malcolm D Tingle, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|June 22, 2001
Determination of the covalent adducts of the novel anti-cancer agent 5,6-dimethylxanthenone-4-acetic acid in biological samples by high-performance liquid chromatographyS Zhou, J W Paxton, M D Tingle, et al.
Neuropharmacology|December 28, 2016
Varenicline improves motor and cognitive deficits and decreases depressive-like behaviour in late-stage YAC128 miceAilsa L McGregor, Gary D'Souza, Donghyo Kim, et al.
Pageof 9